Literature DB >> 29636144

Facial Plastic Surgery Controversies: Keloids.

Kofi Boahene1, Anthony E Brissett2, Lamont R Jones3.   

Abstract

There are more than 11 million people in the world affected with keloids. Nevertheless, there is a lack of agreement in keloid management. Moreover, keloid research has left gaps in the understanding of its pathogenesis. Six questions are answered by 3 clinical scientists in an attempt to address common keloid controversies.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fibroproliferative tumor; Keloid; Keloid prophylaxis; Keloid risk factors; Keloid treatment

Mesh:

Year:  2018        PMID: 29636144     DOI: 10.1016/j.fsc.2017.12.001

Source DB:  PubMed          Journal:  Facial Plast Surg Clin North Am        ISSN: 1064-7406            Impact factor:   1.918


  5 in total

Review 1.  Adjuvant Radiotherapy for Keloids.

Authors:  Wenfang Dong; Bin Qiu; Fei Fan
Journal:  Aesthetic Plast Surg       Date:  2021-08-20       Impact factor: 2.326

2.  Long non-coding RNA CACNA1G-AS1 promotes proliferation and invasion and inhibits apoptosis by regulating expression of miR-205 in human keloid fibroblasts.

Authors:  Xu Zhao; Xiang Jie; Ya-Kun Gao; Bing Nie; Hua Jiang
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

3.  Challenges in the Management of Upper Lid Keloid.

Authors:  Ruchi Goel; Samreen Khanam; Shalin Shah; Ravindra Kumar Saran
Journal:  Case Rep Ophthalmol Med       Date:  2022-03-25

4.  The m6A-methylated mRNA pattern and the activation of the Wnt signaling pathway under the hyper-m6A-modifying condition in the keloid.

Authors:  Can-Xiang Lin; Zhi-Jing Chen; Qi-Lin Peng; Ke-Rong Xiang; Du-Qing Xiao; Ruo-Xi Chen; Taixing Cui; Yue-Sheng Huang; Hong-Wei Liu
Journal:  Front Cell Dev Biol       Date:  2022-10-03

5.  Influence of pharmacological preconditioning on the results of lifting operations efficiency.

Authors:  N E Manturova; V A Stupin; G O Smirnova; E V Silina
Journal:  Heliyon       Date:  2018-08-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.